AI Article Synopsis

  • Infection with high-risk HPV, particularly HPV-18, is linked to aggressive cancer forms and survival challenges.
  • Researchers assessed CD4(+) T cell responses in healthy individuals exposed to specific HPV-18 E6 antigens and found immune reactions in 3 donors.
  • The study suggests that certain E6 peptide sequences trigger CD4 immunity in healthy individuals, indicating a potential for natural immune response against HPV-18.

Article Abstract

Infection by 'high-risk' human papillomaviruses (HPV) is associated with the development of neoplastic lesions. HPV-18 is responsible for a very aggressive form of cancer and poor survival. As for other HPV types, immune surveillance has probably a role in the control of the infection. However, very little is known on HPV-18 immunogenicity. CD4(+) T cells from 16 healthy donors were tested ex vivo for reactivity to synthetic peptides corresponding to 3 sequences on the HPV-18 E6 transforming protein predicted by bioinformatics as promiscuous HLA-DR ligands, and to the recombinant E6 protein. We found 3 donors with CD4(+) T cells that specifically proliferated in the presence of HPV-18 E6 antigens and produced IFN-gamma in the presence of the E6 protein. We then propagated CD4(+) T cell lines and clones from the responsive subjects to better characterize the recognized sequences. We show that E6(52-66) and E6(97-111) are indeed promiscuous and, most importantly, they contain naturally processed epitopes. Collectively, our data indicate that healthy donors may develop spontaneous CD4 immunity against HPV-18 E6 epitopes, thus strongly suggesting the potential for this protein to elicit in the host a natural productive immune response.

Download full-text PDF

Source
http://dx.doi.org/10.1002/eji.200425699DOI Listing

Publication Analysis

Top Keywords

healthy donors
12
cd4+ cell
8
transforming protein
8
naturally processed
8
processed epitopes
8
cd4+ cells
8
protein
5
hpv-18
5
cd4+
4
cell immunity
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!